Dexcom (DXCM) Net Cash Flow Growth (1y) (2011 - 2026)
Dexcom (DXCM) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.52 Bn | 176.22 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.61 Bn | 99.39 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.35 Bn | 66.90 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.86 Bn | 1.29 Bn | -564.44% |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | -31.84% |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | -394.13% |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.49 Bn | 22.36 Bn | 2.07 Bn | 76.43% |
| 10 | Steris | 21.55 Bn | 21.11 Bn | 697.10 Mn | 57.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.84% |
| Dec 31, 2025 | -23,530.77% |
| Sep 30, 2025 | 307.44% |
| Jun 30, 2025 | 166.78% |
| Mar 31, 2025 | 2.70% |
| Dec 31, 2024 | 95.32% |
| Sep 30, 2024 | 40.35% |
| Jun 30, 2024 | -84.47% |
| Mar 31, 2024 | 1,536.32% |
| Dec 31, 2023 | -33.23% |
| Sep 30, 2023 | -1,725.67% |
| Jun 30, 2023 | 2,331.78% |
| Mar 31, 2023 | 94.01% |
| Dec 31, 2022 | 83.99% |
| Sep 30, 2022 | -110.45% |
| Jun 30, 2022 | -94.44% |
| Mar 31, 2022 | -301.32% |
| Dec 31, 2021 | -373.31% |
| Sep 30, 2021 | 101.05% |
| Jun 30, 2021 | 868.84% |